Detalhe da pesquisa
1.
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study.
Cancer Sci
; 113(8): 2788-2797, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35633184
2.
Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors.
CPT Pharmacometrics Syst Pharmacol
; 12(9): 1262-1273, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37496366
3.
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
J Clin Oncol
; 41(36): 5536-5549, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651655
4.
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial.
J Clin Oncol
; 37(31): 2825-2834, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31487218